Notably, these experiments were conducted in the absence of chemerin and CMKLR1, indicating that the observed effects were independent of the chemerin/CMKLR1 axis and solely attributable to CCRL2 expression in tumor cells. The gene discussed is RARRES2; the disease is neoplasm.